Savaysa Safe for Afib Cardioversion

ACC Conference Reporter

ESC Congress 2016 | ROME — Edoxaban (Savaysa) appears at least as safe as the standard warfarin (Coumadin)/enoxaparin (Lovenox) strategy for use in bridging anticoagulation around cardioversion for recent onset atrial fibrillation (afib), the ENSURE-AF trial showed. Read More >>>

Keywords: ESC Congress


< Back to Listings